Summary of share price highs, lows and changes for Atlas Arteria
Historical stock prices
Current Share Price	AU$4.48
52 Week High	AU$5.40
52 Week Low	AU$4.20
Beta	0.52
1 Month Change	-9.86%
3 Month Change	-11.81%
1 Year Change	-14.18%
3 Year Change	-23.42%
5 Year Change	-32.33%
Change since IPO	628.46%

Recent News & Updates

New Narrative • Jul 11

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

At $5.13 per share, Atlas Arteria (ASX: ALX) appears reasonably valued based on its current operating performance, with 2025 proportional toll revenue of approximately $2.01 billion and proportional EBITDA of $1.51 billion, representing an EBITDA margin of around 75%. Proportional toll revenue and EBITDA increased by 9.4% and 9.3% respectively, while the 40 cent per share distribution represents a yield of approximately 7.8% at the assessed price.

Recent updates

New Narrative • Jul 11

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

Shareholder Returns

	ALX	AU Infrastructure	AU Market
7D	-0.9%	-0.05%	-0.6%
1Y	-14.2%	-4.4%	-0.3%

Return vs Industry: ALX underperformed the Australian Infrastructure industry which returned -4.4% over the past year.

Return vs Market: ALX underperformed the Australian Market which returned -0.3% over the past year.

Price Volatility

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	1.7%
Infrastructure Industry Average Movement	2.9%
Market Average Movement	9.7%
10% most volatile stocks in AU Market	16.9%
10% least volatile stocks in AU Market	4.0%

Stable Share Price: ALX has not had significant price volatility in the past 3 months compared to the Australian market.

Volatility Over Time: ALX's weekly volatility (2%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited owns, develops, and operates toll roads in France, Germany, Australia, Bermuda, and the United States. It holds 30.82% interest in the APRR motorway network, 30.85% interest in the ADELAC commuter road, and 30.79% interest in the A79 transversal link located in France; 100% interest in the Warnow Tunnel located in Rostock, Germany; 66.67% interest in the Chicago Skyway situated in Chicago, United States; and 100% interest in the Dulles Greenway located in Virginia, United States. Atlas Arteria Limited was formerly known as Macquarie Atlas Roads Limited and changed its name to Atlas Arteria Limited in May 2018.

Atlas Arteria Limited Fundamentals Summary

How do Atlas Arteria's earnings and revenue compare to its market cap?
ALX fundamental statistics
Market cap	AU$6.66b
Earnings (TTM)	AU$268.70m
Revenue (TTM)	AU$156.80m

24.2x

P/E Ratio

41.5x

P/S Ratio

Is ALX overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ALX income statement (TTM)
Revenue	AU$156.80m
Cost of Revenue	AU$81.20m
Gross Profit	AU$75.60m
Other Expenses	-AU$193.10m
Earnings	AU$268.70m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	0.19
Gross Margin	48.21%
Net Profit Margin	171.36%
Debt/Equity Ratio	30.3%

How did ALX perform over the long term?

See historical performance and comparison

Dividends

8.9%

Current Dividend Yield

108%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/09/10 08:42
End of Day Share Price	2026/09/10 00:00
Earnings	2026/06/30
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Atlas Arteria Limited is covered by 16 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Matthew Ryan	Barrenjoey Markets Pty Limited
Shaurya Visen	BofA Global Research
Richard Lee	BofA Global Research

Atlas Arteria (ALX) Stock Overview

Rewards

Risk Analysis

Top Community Narratives

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

Top Community Narratives

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

Atlas Arteria Limited Competitors

Transurban Group

Aurizon Holdings

Dalrymple Bay Infrastructure

Qantas Airways

Price History & Performance

Recent News & Updates

Consensus EPS estimates fall by 29%

First half 2026 earnings released: EPS: AU$0.08 (vs AU$0.074 in 1H 2025)

New minor risk - Earnings quality

CEO, MD & Director exercised options to buy AU$6.1m worth of stock.

Consensus EPS estimates increase by 12%

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

Recent updates

Consensus EPS estimates fall by 29%

First half 2026 earnings released: EPS: AU$0.08 (vs AU$0.074 in 1H 2025)

New minor risk - Earnings quality

CEO, MD & Director exercised options to buy AU$6.1m worth of stock.

Consensus EPS estimates increase by 12%

Are You IFM-ing Me? Assessing ALX at $5.13 per Share

IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd completed the acquisition of an additional 32.96% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 2.44 billion.

Atlas Arteria Limited Announces Board and Committee Changes

Atlas Arteria Board Rejects IFM’s A$7.4 Billion Takeover Offer After 18% Premium Bid

Takeovers Panel Clears Path for IFM’s A$7b Bid as Atlas Arteria Board Stands Firm

Investor sentiment improves as stock rises 15%

IFM Global Infrastructure Fund managed by IFM Investors Pty Ltd proposed to acquire remaining 65.52% stake in Atlas Arteria Limited (ASX:ALX) from Lazard Asset Management Limited, BlackRock, Inc. (NYSE:BLK) and State Street Corporation (NYSE:STT) and others for AUD 4.5 billion.

Consensus EPS estimates fall by 20%

Final dividend of AU$0.20 announced

Atlas Arteria Limited to Report First Half, 2026 Results on Aug 26, 2026

Atlas Arteria Limited, Annual General Meeting, May 13, 2026

Consensus EPS estimates fall by 18%

Full year 2025 earnings released: EPS: AU$0.18 (vs AU$0.23 in FY 2024)

Atlas Arteria Limited to Report Fiscal Year 2025 Results on Feb 26, 2026

First half dividend of AU$0.20 announced

Consensus revenue estimates increase by 39%

First half 2025 earnings released: EPS: AU$0.074 (vs AU$0.099 in 1H 2024)

Atlas Arteria Limited Announces Virginia Supreme Court Decision Affirms SCC Rate Case Appeal

Consensus EPS estimates increase by 14%

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2024, Payable on 4 April 2025

Atlas Arteria Limited, Annual General Meeting, May 15, 2025

Consensus EPS estimates fall by 10%

Full year 2024 earnings: EPS and revenues miss analyst expectations

Atlas Arteria Limited Reaffirms Distribution Guidance for Second Half of 2024

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%